Analysts Set Stericycle, Inc. (NASDAQ:SRCL) PT at $62.25

Stericycle, Inc. (NASDAQ:SRCL) has received a consensus recommendation of “Hold” from the five analysts that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and two have assigned a buy recommendation to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $60.80.

Several research analysts have recently commented on SRCL shares. Truist Financial lifted their price target on Stericycle from $50.00 to $57.00 and gave the stock a “hold” rating in a report on Thursday, February 29th. Robert W. Baird reduced their price target on Stericycle from $62.00 to $55.00 and set a “neutral” rating on the stock in a report on Friday. Royal Bank of Canada reiterated an “outperform” rating and set a $69.00 price target on shares of Stericycle in a report on Thursday, March 7th. StockNews.com lowered Stericycle from a “buy” rating to a “hold” rating in a report on Tuesday, April 2nd. Finally, Stifel Nicolaus raised their price objective on Stericycle from $70.00 to $75.00 and gave the stock a “buy” rating in a research report on Thursday, February 29th.

Stericycle Trading Down 0.4 %

Shares of SRCL stock opened at $46.31 on Friday. The stock’s fifty day moving average is $51.35 and its two-hundred day moving average is $48.24. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.94 and a current ratio of 1.11. The firm has a market capitalization of $4.30 billion, a P/E ratio of -210.50, a PEG ratio of 2.49 and a beta of 1.09. Stericycle has a fifty-two week low of $37.78 and a fifty-two week high of $57.06.

Stericycle (NASDAQ:SRCL) last announced its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.57 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.03. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. The company had revenue of $664.90 million for the quarter, compared to analyst estimates of $676.42 million. During the same quarter last year, the firm posted $0.49 EPS. The firm’s revenue for the quarter was down 2.8% on a year-over-year basis. Research analysts expect that Stericycle will post 2.32 earnings per share for the current fiscal year.

Institutional Trading of Stericycle

Hedge funds and other institutional investors have recently modified their holdings of the business. Principal Securities Inc. acquired a new position in Stericycle in the 4th quarter valued at about $41,000. GAMMA Investing LLC grew its position in Stericycle by 170.9% in the 1st quarter. GAMMA Investing LLC now owns 818 shares of the business services provider’s stock valued at $43,000 after acquiring an additional 516 shares in the last quarter. TFO Wealth Partners LLC grew its position in Stericycle by 22,325.0% in the 4th quarter. TFO Wealth Partners LLC now owns 897 shares of the business services provider’s stock valued at $44,000 after acquiring an additional 893 shares in the last quarter. Exchange Traded Concepts LLC grew its position in Stericycle by 87.5% in the 3rd quarter. Exchange Traded Concepts LLC now owns 1,001 shares of the business services provider’s stock valued at $45,000 after acquiring an additional 467 shares in the last quarter. Finally, Ramirez Asset Management Inc. acquired a new position in Stericycle in the 3rd quarter valued at about $45,000. 98.82% of the stock is owned by institutional investors and hedge funds.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.